Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
63,682.91 +235.96 (+0.37%) CMC Crypto 200
1,368.13 +55.50 (+4.23%)
Twist Bioscience Corporation (TWST)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.64B |
| Enterprise value | 1.42B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.17 |
| Price/book (mrq) | 2.78 |
| Enterprise value/revenue | 5.41 |
| Enterprise value/EBITDA | -8.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.62 |
| 52-week change 3 | 106.25% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 43.21 |
| 52-week low 3 | 11.46 |
| 50-day moving average 3 | 35.61 |
| 200-day moving average 3 | 27.33 |
Share statistics
| Avg vol (3-month) 3 | 876.96k |
| Avg vol (10-day) 3 | 753.39k |
| Shares outstanding 5 | 57.82M |
| Implied shares outstanding 6 | 57.82M |
| Float 8 | 56.87M |
| % held by insiders 1 | 1.78% |
| % held by institutions 1 | 112.68% |
| Shares short (28 Mar 2024) 4 | 12.26M |
| Short ratio (28 Mar 2024) 4 | 16.8 |
| Short % of float (28 Mar 2024) 4 | 27.80% |
| Short % of shares outstanding (28 Mar 2024) 4 | 21.20% |
| Shares short (prior month 29 Feb 2024) 4 | 12.4M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -78.44% |
| Operating margin (ttm) | -65.70% |
Management effectiveness
| Return on assets (ttm) | -15.87% |
| Return on equity (ttm) | -30.80% |
Income statement
| Revenue (ttm) | 262.36M |
| Revenue per share (ttm) | 4.59 |
| Quarterly revenue growth (yoy) | 31.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -176.4M |
| Net income avi to common (ttm) | -205.8M |
| Diluted EPS (ttm) | -3.61 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 311.14M |
| Total cash per share (mrq) | 5.38 |
| Total debt (mrq) | 91.88M |
| Total debt/equity (mrq) | 15.57% |
| Current ratio (mrq) | 5.98 |
| Book value per share (mrq) | 10.21 |
Cash flow statement
| Operating cash flow (ttm) | -111.38M |
| Levered free cash flow (ttm) | -67.14M |
© 2024 Yahoo. All rights reserved.